1. Home
  2. IPHA vs SGC Comparison

IPHA vs SGC Comparison

Compare IPHA & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.76

Market Cap

189.5M

Sector

Health Care

ML Signal

HOLD

Logo Superior Group of Companies Inc.

SGC

Superior Group of Companies Inc.

HOLD

Current Price

$13.55

Market Cap

181.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPHA
SGC
Founded
1999
1920
Country
France
United States
Employees
163
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
189.5M
181.8M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
IPHA
SGC
Price
$1.76
$13.55
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$5.75
$16.00
AVG Volume (30 Days)
8.0K
53.4K
Earning Date
03-26-2026
05-04-2026
Dividend Yield
N/A
4.93%
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
N/A
$566,184,000.00
Revenue This Year
$180.36
$3.23
Revenue Next Year
N/A
$3.82
P/E Ratio
N/A
$220.50
Revenue Growth
N/A
0.09
52 Week Low
$1.18
$8.30
52 Week High
$2.63
$14.59

Technical Indicators

Market Signals
Indicator
IPHA
SGC
Relative Strength Index (RSI) 49.08 55.85
Support Level $1.73 $9.62
Resistance Level $1.80 $14.59
Average True Range (ATR) 0.09 0.56
MACD -0.01 -0.01
Stochastic Oscillator 23.81 82.48

Price Performance

Historical Comparison
IPHA
SGC

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.

Share on Social Networks: